Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-STOP study of pre-procedural aspirin for ruptured cerebral aneurysm coil embolization
jRCTs031210421Active, not recruiting
- Sponsor
- The Japanese Society for Neuroendovascular Therapy
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Aspirin with Placebo (2 arms). Primary endpoints: Incidence of intraoperative thrombotic complication and Incidence of symptomatic ischemic lesions on MRI-DWI (IRC). Started Jan 2022; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on jRCTs031210421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210421.